<DOC>
	<DOCNO>NCT00534079</DOCNO>
	<brief_summary>Rhinosinusitis disorder often associate Cystic Fibrosis . They restrict quality life enormously give cause repeat ENT surgery . The basic defect CF dysfunction chloride channel exocrine gland , lead retention secretion consecutive chronic inflammation bacterial superinfection . The prospective placebo control cross-over study aim evaluation nasally inhalation Pulmozyme respect mucus retention result inflammation .</brief_summary>
	<brief_title>Nasal Inhalation Pulmozyme Patients With Cystic Fibrosis Chronic Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<criteria>Subject confirm diagnosis cystic fibrosis base : 3 positive sweat chloride test and/or genetic characterisation Subject 5 year age old Subject chronic recurrent rhinosinusitic disorder Subject able comply procedure schedule protocol Women childbearing potential include study , use effective method birth control protocol ( e.g . implant , combine oral contraceptive , injectables , IUDs , sexual abstinence vasectomise partner ) Subject critical condition define : FEV1 &lt; 30 % / SaO2 &lt; 93 % without O2substitution ; need O2substitution Subject ENT surgery within 6 month prior study Subject show sign nasal bleed Subject ear drum perforation Subject acute rhinosinusitis pulmonary exacerbation study entry need additional systemic antibiotic therapy Subject new therapy nasal topic steroid treatment interval Subject new systemic steroid therapy Subject unlikely comply procedure schedule protocol Subject know allergic reaction medication Subject pregnant breastfeeding Patient participate another clinical trial within 30 day prior study entry 30 day end study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cystic Fibrosis chronic rhinosinusitis</keyword>
</DOC>